Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin Therapy for Women With Diminished Ovarian Reserve Undergoing ICSI
NCT07318974Phase 2Active, not recruiting
- Sponsor
- Benha University
- Start
- Sep 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melatonin in Diminished Ovarian Reserve (DOR), sponsored by Benha University. Started Sep 2025; status: active, not recruiting.
02
Drugs
melatonin
03
Conditions
Diminished Ovarian Reserve (DOR)
Beyond the preview
Go deeper on NCT07318974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07318974.